Healthcare Sector Stocks
The Healthcare sector has a total of 1050 stocks, with a combined market cap of $9.9 trillion, total revenue of $4.73 trillion and a weighted average PE ratio of 46.84.
Market Cap
9.9T
Revenue
4.73T
Profits
211.35B
PE Ratio
46.84
Profit Margin
4.47%
Dividend Yield
0.38%
1050 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.22T | -3.76% | 4,888,505 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 655.56B | -1.45% | 9,661,395 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 509.50B | -2.24% | 7,970,772 | 66.01B |
| 4 | MRK | Merck & Co., Inc. | 362.24B | -2.27% | 11,547,646 | 67.38B |
| 5 | UNH | UnitedHealth Group Incorporated | 354.57B | -3.34% | 6,890,935 | 450.06B |
| 6 | NVS | Novartis AG | 310.78B | -1.85% | 2,440,163 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 293.41B | -1.14% | 4,842,575 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 250.82B | -4.14% | 2,835,880 | 47.35B |
| 9 | AMGN | Amgen Inc. | 248.97B | -3.80% | 4,106,795 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 207.84B | -3.96% | 11,355,970 | 30.99B |
| 11 | ABT | Abbott Laboratories | 196.75B | -1.65% | 10,285,272 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 179.56B | -4.46% | 18,499,393 | 50.70B |
| 13 | PFE | Pfizer Inc. | 170.31B | -2.96% | 53,051,021 | 63.62B |
| 14 | ISRG | Intuitive Surgical, Inc. | 162.41B | -2.82% | 4,698,422 | 11.58B |
| 15 | DHR | Danaher Corporation | 159.24B | -3.66% | 5,138,041 | 25.61B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 137.54B | -1.19% | 2,483,184 | 12.95B |
| 17 | BMY | Bristol-Myers Squibb Company | 129.04B | -1.65% | 9,026,833 | 50.03B |
| 18 | MDT | Medtronic plc | 128.34B | -0.11% | 11,648,113 | 37.54B |
| 19 | SYK | Stryker Corporation | 127.56B | -1.35% | 4,459,499 | 26.30B |
| 20 | MCK | McKesson Corporation | 123.77B | 0.24% | 1,285,779 | 418.79B |
| 21 | SNY | Sanofi | 113.65B | -1.18% | 7,110,784 | 57.89B |
| 22 | HCA | HCA Healthcare, Inc. | 106.01B | -0.63% | 1,657,614 | 78.70B |
| 23 | CVS | CVS Health Corporation | 104.06B | 1.71% | 19,930,576 | 418.16B |
| 24 | GSK | GSK plc | 102.07B | -1.45% | 3,059,893 | 44.53B |
| 25 | MRNA | Moderna, Inc. | 96.40B | -6.55% | 12,032,003 | 2.23B |
| 26 | ELV | Elevance Health, Inc. | 93.34B | -0.50% | 2,113,759 | 201.83B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 90.60B | -2.98% | 1,407,352 | 16.90B |
| 28 | CI | The Cigna Group | 79.66B | -1.29% | 2,769,247 | 286.32B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 69.67B | 0.62% | 4,735,017 | 29.86B |
| 30 | COR | Cencora, Inc. | 64.82B | -4.05% | 2,487,442 | 337.40B |
| 31 | BSX | Boston Scientific Corporation | 64.70B | -2.58% | 22,492,479 | 21.07B |
| 32 | CAH | Cardinal Health, Inc. | 62.02B | 2.25% | 2,998,225 | 257.75B |
| 33 | BDX | Becton, Dickinson and Company | 58.17B | 2.08% | 3,991,907 | 19.46B |
| 34 | EW | Edwards Lifesciences Corporation | 57.97B | 1.46% | 9,233,947 | 6.67B |
| 35 | ARGX | argenx SE | 57.24B | -3.93% | 399,494 | 5.92B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 52.84B | -3.99% | 873,282 | 4.66B |
| 37 | NTRA | Natera, Inc. | 52.43B | -6.97% | 3,234,626 | 2.91B |
| 38 | MDLN | Medline Inc. | 52.30B | -1.46% | 14,221,167 | 30.68B |
| 39 | VEEV | Veeva Systems Inc. | 50.21B | -0.17% | 2,151,856 | 3.46B |
| 40 | HUM | Humana Inc. | 49.45B | -1.35% | 1,362,855 | 145.68B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 48.75B | -0.17% | 13,709,667 | 17.23B |
| 42 | A | Agilent Technologies, Inc. | 48.43B | -3.04% | 2,698,888 | 7.37B |
| 43 | WAT | Waters Corporation | 44.51B | -3.11% | 1,149,804 | 5.61B |
| 44 | ONC | BeOne Medicines AG | 44.03B | 2.51% | 959,821 | 6.61B |
| 45 | IQV | IQVIA Holdings Inc. | 43.65B | 0.41% | 1,738,216 | 17.31B |
| 46 | HLN | Haleon plc | 40.35B | -0.87% | 38,366,776 | 14.80B |
| 47 | RPRX | Royalty Pharma plc | 38.76B | 0.01% | 4,896,670 | 2.62B |
| 48 | RVMD | Revolution Medicines, Inc. | 38.08B | -11.04% | 7,807,861 | 197.56M |
| 49 | GEHC | GE HealthCare Technologies Inc. | 37.87B | -2.40% | 6,227,621 | 21.64B |
| 50 | ALC | Alcon Inc. | 37.23B | -0.98% | 2,633,145 | 10.86B |
| 51 | CNC | Centene Corporation | 36.72B | -2.42% | 7,709,987 | 180.41B |
| 52 | BIIB | Biogen Inc. | 36.06B | -4.14% | 1,221,067 | 10.30B |
| 53 | ZTS | Zoetis Inc. | 33.93B | -7.95% | 10,087,800 | 9.52B |
| 54 | RMD | ResMed Inc. | 33.66B | -0.50% | 1,695,458 | 5.73B |
| 55 | MTD | Mettler-Toledo International Inc. | 33.64B | -2.56% | 294,573 | 4.20B |
| 56 | GMAB | Genmab A/S | 32.61B | -4.32% | 4,400,181 | 4.30B |
| 57 | DXCM | DexCom, Inc. | 31.50B | -4.54% | 4,922,769 | 5.10B |
| 58 | ILMN | Illumina, Inc. | 31.45B | -8.18% | 4,236,753 | 4.54B |
| 59 | PHG | Koninklijke Philips N.V. | 30.18B | -1.77% | 3,190,992 | 20.16B |
| 60 | LH | Labcorp Holdings Inc. | 29.50B | -1.22% | 775,273 | 14.59B |
| 61 | DGX | Quest Diagnostics Incorporated | 28.03B | -0.37% | 969,318 | 11.84B |
| 62 | WST | West Pharmaceutical Services, Inc. | 27.34B | -3.99% | 872,911 | 3.40B |
| 63 | ROIV | Roivant Sciences Ltd. | 26.45B | -4.21% | 10,177,245 | 7.53M |
| 64 | STE | STERIS plc | 24.78B | 2.50% | 1,652,652 | 6.17B |
| 65 | UTHR | United Therapeutics Corporation | 24.09B | -7.03% | 619,733 | 3.19B |
| 66 | INCY | Incyte Corporation | 24.05B | -3.94% | 1,600,120 | 6.01B |
| 67 | INSM | Insmed Incorporated | 23.86B | -1.13% | 2,616,309 | 1.52B |
| 68 | THC | Tenet Healthcare Corporation | 22.80B | -1.98% | 1,068,706 | 22.15B |
| 69 | VTRS | Viatris Inc. | 21.75B | -1.30% | 11,924,733 | 14.73B |
| 70 | BNTX | BioNTech SE | 21.29B | -5.34% | 1,191,074 | 2.75B |
| 71 | ALNY | Alnylam Pharmaceuticals, Inc. | 20.98B | -2.74% | 3,314,550 | 5.01B |
| 72 | GH | Guardant Health, Inc. | 20.59B | -8.99% | 4,080,261 | 1.28B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 20.22B | -3.00% | 3,623,765 | 8.57B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.76B | -3.32% | 315,869 | 2.84B |
| 75 | RVTY | Revvity, Inc. | 16.83B | -5.39% | 2,295,197 | 2.94B |
| 76 | EXEL | Exelixis, Inc. | 16.77B | -5.55% | 4,376,152 | 2.50B |
| 77 | ASND | Ascendis Pharma A/S | 16.64B | -1.74% | 557,635 | 1.20B |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 16.17B | -3.79% | 1,483,169 | 3.70B |
| 79 | ICLR | ICON Public Limited Company | 15.11B | -0.72% | 1,475,370 | 8.23B |
| 80 | CRL | Charles River Laboratories International, Inc. | 15.00B | -4.07% | 1,662,200 | 3.98B |
| 81 | SOLV | Solventum Corporation | 14.84B | -2.43% | 1,880,739 | 8.16B |
| 82 | JAZZ | Jazz Pharmaceuticals plc | 14.59B | -3.13% | 670,560 | 4.72B |
| 83 | BBIO | BridgeBio Pharma, Inc. | 14.47B | -4.65% | 3,383,646 | 945.54M |
| 84 | HALO | Halozyme Therapeutics, Inc. | 13.96B | -5.66% | 2,896,633 | 1.80B |
| 85 | EHC | Encompass Health Corporation | 13.86B | 0.17% | 1,560,581 | 6.34B |
| 86 | BTSG | BrightSpring Health Services, Inc. | 13.72B | -5.64% | 3,809,827 | 15.25B |
| 87 | SNN | Smith & Nephew plc | 13.34B | -1.39% | 2,818,362 | 6.30B |
| 88 | BAX | Baxter International Inc. | 13.27B | -3.21% | 10,103,100 | 11.61B |
| 89 | GKOS | Glaukos Corporation | 13.02B | -10.83% | 2,042,314 | 690.33M |
| 90 | TEM | Tempus AI, Inc. | 12.85B | -6.85% | 10,005,798 | 1.51B |
| 91 | PEN | Penumbra, Inc. | 12.66B | -0.42% | 310,539 | 1.56B |
| 92 | FMS | Fresenius Medical Care AG | 12.32B | 2.03% | 1,471,037 | 22.12B |
| 93 | DVA | DaVita Inc. | 12.26B | 1.12% | 633,522 | 14.17B |
| 94 | COO | The Cooper Companies, Inc. | 12.08B | -1.41% | 2,381,361 | 4.24B |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 12.00B | -1.62% | 4,808,229 | 3.44B |
| 96 | ELAN | Elanco Animal Health Incorporated | 11.83B | -6.44% | 6,712,169 | 5.02B |
| 97 | UHS | Universal Health Services, Inc. | 11.70B | 1.08% | 1,316,064 | 18.35B |
| 98 | TECH | Bio-Techne Corporation | 11.39B | -0.10% | 4,506,978 | 1.22B |
| 99 | SMMT | Summit Therapeutics Inc. | 11.35B | -12.24% | 5,940,026 | - |
| 100 | MOH | Molina Healthcare, Inc. | 11.29B | -4.32% | 928,208 | 42.08B |
| 101 | ALGN | Align Technology, Inc. | 11.23B | -3.35% | 1,387,251 | 4.16B |
| 102 | KYMR | Kymera Therapeutics, Inc. | 10.94B | -5.97% | 1,728,951 | 102.24M |
| 103 | GMED | Globus Medical, Inc. | 10.93B | -6.50% | 4,093,705 | 3.14B |
| 104 | BMRN | BioMarin Pharmaceutical Inc. | 10.87B | -1.77% | 2,164,802 | 3.66B |
| 105 | PODD | Insulet Corporation | 10.83B | -5.39% | 1,319,327 | 3.19B |
| 106 | RGEN | Repligen Corporation | 10.77B | -5.45% | 1,332,429 | 805.61M |
| 107 | ENSG | The Ensign Group, Inc. | 10.55B | -3.14% | 397,559 | 5.67B |
| 108 | QGEN | Qiagen N.V. | 10.50B | 0.06% | 4,627,363 | 2.12B |
| 109 | AVTR | Avantor, Inc. | 10.26B | -3.26% | 7,464,739 | 6.64B |
| 110 | OSCR | Oscar Health, Inc. | 10.23B | -5.71% | 11,560,630 | 17.47B |
| 111 | BIO | Bio-Rad Laboratories, Inc. | 9.92B | -2.89% | 433,889 | 2.59B |
| 112 | PCVX | Vaxcyte, Inc. | 9.80B | -5.72% | 1,833,845 | - |
| 113 | HSIC | Henry Schein, Inc. | 9.43B | -3.32% | 2,098,133 | 13.73B |
| 114 | HNGE | Hinge Health, Inc. | 9.36B | -4.05% | 2,653,955 | 800.82M |
| 115 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.29B | -0.08% | 857,711 | 1.43B |
| 116 | SYRE | Spyre Therapeutics, Inc. | 9.17B | -2.47% | 1,160,384 | - |
| 117 | ATR | AptarGroup, Inc. | 9.13B | -1.92% | 693,450 | 3.99B |
| 118 | KRYS | Krystal Biotech, Inc. | 8.90B | -3.41% | 400,941 | 470.03M |
| 119 | BRKR | Bruker Corporation | 8.85B | -8.98% | 3,263,773 | 3.51B |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 8.75B | -5.66% | 584,679 | 551.69M |
| 121 | HQY | HealthEquity, Inc. | 8.56B | -4.94% | 1,382,829 | 1.36B |
| 122 | IBRX | ImmunityBio, Inc. | 8.49B | -10.30% | 12,562,959 | 165.79M |
| 123 | TGTX | TG Therapeutics, Inc. | 8.22B | -5.92% | 2,112,610 | 799.54M |
| 124 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.12B | -6.80% | 1,805,967 | 669.50M |
| 125 | PACS | PACS Group, Inc. | 7.97B | -0.12% | 1,563,330 | 5.71B |
| 126 | CORT | Corcept Therapeutics Incorporated | 7.84B | -9.58% | 1,508,024 | 963.65M |
| 127 | CYTK | Cytokinetics, Incorporated | 7.72B | -12.66% | 6,776,024 | 113.29M |
| 128 | ABVX | ABIVAX Société Anonyme | 7.60B | -5.94% | 1,235,452 | 5.33M |
| 129 | TXG | 10x Genomics, Inc. | 7.56B | -14.01% | 5,969,110 | 618.58M |
| 130 | TWST | Twist Bioscience Corporation | 7.56B | -15.41% | 3,091,626 | 431.80M |
| 131 | GRFS | Grifols, S.A. | 7.53B | -1.74% | 761,428 | 8.63B |
| 132 | ALKS | Alkermes plc | 7.48B | -2.94% | 1,943,983 | 1.75B |
| 133 | CAI | Caris Life Sciences, Inc. | 7.47B | -21.64% | 7,829,189 | 1.05B |
| 134 | PRAX | Praxis Precision Medicines, Inc. | 7.33B | -7.80% | 339,307 | 7.46M |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.28B | -5.11% | 6,396,437 | 280.75M |
| 136 | BLCO | Bausch + Lomb Corporation | 7.12B | -3.30% | 699,442 | 5.42B |
| 137 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.94B | -8.09% | 961,609 | 945.96M |
| 138 | CHE | Chemed Corporation | 6.92B | -2.71% | 143,422 | 2.66B |
| 139 | AXSM | Axsome Therapeutics, Inc. | 6.83B | -5.26% | 1,109,526 | 865.27M |
| 140 | AMRX | Amneal Pharmaceuticals, Inc. | 6.77B | -2.51% | 4,948,969 | 3.20B |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.57B | -0.44% | 1,233,895 | 1.56B |
| 142 | IONS | Ionis Pharmaceuticals, Inc. | 6.45B | -3.36% | 2,975,955 | 874.09M |
| 143 | TFX | Teleflex Incorporated | 6.45B | 1.52% | 1,417,534 | 2.25B |
| 144 | ORKA | Oruka Therapeutics, Inc. | 6.36B | -5.32% | 847,049 | - |
| 145 | RDNT | RadNet, Inc. | 6.14B | -2.80% | 1,050,713 | 2.27B |
| 146 | MIRM | Mirum Pharmaceuticals, Inc. | 6.11B | -3.54% | 871,315 | 670.78M |
| 147 | LGND | Ligand Pharmaceuticals Incorporated | 5.98B | -5.42% | 247,629 | 253.83M |
| 148 | DOCS | Doximity, Inc. | 5.91B | -4.30% | 2,661,415 | 661.58M |
| 149 | IMVT | Immunovant, Inc. | 5.86B | -5.05% | 1,120,803 | - |
| 150 | BLTE | Belite Bio, Inc | 5.77B | -7.03% | 223,503 | - |
| 151 | CGON | CG Oncology, Inc. | 5.74B | -4.30% | 931,579 | 6.23M |
| 152 | KOD | Kodiak Sciences Inc. | 5.71B | -7.60% | 1,101,356 | - |
| 153 | HAE | Haemonetics Corporation | 5.65B | -2.60% | 1,302,144 | 1.38B |
| 154 | HIMS | Hims & Hers Health, Inc. | 5.61B | -9.75% | 17,589,262 | 2.58B |
| 155 | WAY | Waystar Holding Corp. | 5.56B | -2.73% | 2,381,064 | 1.26B |
| 156 | SUPN | Supernus Pharmaceuticals, Inc. | 5.55B | -5.21% | 6,080,380 | 1.37B |
| 157 | SRRK | Scholar Rock Holding Corporation | 5.54B | -1.28% | 1,455,726 | - |
| 158 | PTCT | PTC Therapeutics, Inc. | 5.49B | -4.78% | 1,238,536 | 1.16B |
| 159 | CON | Concentra Group Holdings Parent, Inc. | 5.37B | -3.24% | 1,899,102 | 2.34B |
| 160 | MANE | Veradermics, Incorporated | 5.37B | -5.79% | 788,212 | - |
| 161 | MMSI | Merit Medical Systems, Inc. | 5.37B | -1.11% | 940,188 | 1.61B |
| 162 | GRAL | GRAIL, Inc. | 5.33B | -17.08% | 2,096,581 | 166.60M |
| 163 | BLLN | BillionToOne, Inc. | 5.30B | -1.32% | 1,684,978 | 436.87M |
| 164 | COGT | Cogent Biosciences, Inc. | 5.13B | -6.07% | 2,725,035 | - |
| 165 | MMED | MiniMed Group, Inc. | 5.11B | -5.88% | 10,043,560 | 3.22B |
| 166 | LFST | LifeStance Health Group, Inc. | 5.11B | -5.49% | 11,036,332 | 1.68B |
| 167 | LIVN | LivaNova PLC | 5.02B | -3.24% | 1,242,604 | 1.51B |
| 168 | OPCH | Option Care Health, Inc. | 4.72B | -0.47% | 4,756,921 | 5.75B |
| 169 | CRSP | CRISPR Therapeutics AG | 4.71B | -6.22% | 2,153,082 | 25.17M |
| 170 | TVTX | Travere Therapeutics, Inc. | 4.69B | -6.77% | 2,192,831 | 651.03M |
| 171 | DNTH | Dianthus Therapeutics, Inc. | 4.64B | -3.26% | 1,058,520 | 2.72M |
| 172 | ERAS | Erasca, Inc. | 4.64B | -11.00% | 6,689,769 | - |
| 173 | SHC | Sotera Health Company | 4.53B | -3.17% | 3,141,366 | 1.23B |
| 174 | HTFL | HeartFlow, Inc. | 4.52B | -8.17% | 2,147,179 | 212.07M |
| 175 | LEGN | Legend Biotech Corporation | 4.37B | -1.01% | 3,232,593 | 1.27B |
| 176 | ADPT | Adaptive Biotechnologies Corporation | 4.34B | 0.45% | 4,045,321 | 298.01M |
| 177 | ITGR | Integer Holdings Corporation | 4.31B | 0.09% | 1,012,966 | 1.83B |
| 178 | IRTC | iRhythm Holdings, Inc. | 4.29B | -2.84% | 797,694 | 854.04M |
| 179 | EWTX | Edgewise Therapeutics, Inc. | 4.22B | 3.57% | 5,216,802 | - |
| 180 | ICUI | ICU Medical, Inc. | 4.19B | -2.88% | 529,574 | 2.18B |
| 181 | DFTX | Definium Therapeutics, Inc. | 4.08B | -7.16% | 1,915,662 | - |
| 182 | CDNA | CareDx, Inc. | 4.01B | -11.10% | 2,062,085 | 497.40M |
| 183 | NVST | Envista Holdings Corporation | 4.00B | -8.20% | 5,488,182 | 2.88B |
| 184 | LQDA | Liquidia Corporation | 3.98B | -6.10% | 2,142,073 | 450.91M |
| 185 | PLSE | Pulse Biosciences, Inc. | 3.79B | -6.99% | 534,456 | 1.49M |
| 186 | RLAY | Relay Therapeutics, Inc. | 3.73B | -5.71% | 4,720,967 | 10.35M |
| 187 | ACAD | Acadia Pharmaceuticals Inc. | 3.66B | -1.07% | 6,027,494 | 1.20B |
| 188 | XENE | Xenon Pharmaceuticals Inc. | 3.65B | -3.85% | 1,036,787 | 7.50M |
| 189 | OGN | Organon & Co. | 3.62B | -0.29% | 3,756,468 | 6.10B |
| 190 | STVN | Stevanato Group S.p.A. | 3.61B | -1.71% | 4,493,929 | 1.42B |
| 191 | ABCL | AbCellera Biologics Inc. | 3.61B | -9.36% | 4,149,514 | 66.17M |
| 192 | TNGX | Tango Therapeutics, Inc. | 3.52B | -9.97% | 3,409,237 | 53.81M |
| 193 | IOVA | Iovance Biotherapeutics, Inc. | 3.51B | -11.03% | 23,403,697 | 378.98M |
| 194 | IRON | Disc Medicine, Inc. | 3.48B | -5.78% | 932,690 | - |
| 195 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.47B | -6.05% | 2,210,150 | -665.00K |
| 196 | PBLS | Parabilis Medicines, Inc. | 3.44B | -8.17% | 920,738 | 148.00K |
| 197 | ARQT | Arcutis Biotherapeutics, Inc. | 3.41B | -20.70% | 7,602,220 | 508.68M |
| 198 | TARS | Tarsus Pharmaceuticals, Inc. | 3.33B | -2.24% | 1,716,287 | 682.20M |
| 199 | VKTX | Viking Therapeutics, Inc. | 3.29B | -7.79% | 4,849,376 | - |
| 200 | ELVN | Enliven Therapeutics, Inc. | 3.28B | -5.21% | 1,585,854 | - |
| 201 | NHC | National HealthCare Corporation | 3.25B | -2.25% | 120,959 | 1.58B |
| 202 | VRDN | Viridian Therapeutics, Inc. | 3.24B | -1.75% | 3,437,520 | 26.31M |
| 203 | DYN | Dyne Therapeutics, Inc. | 3.24B | -6.36% | 3,203,982 | - |
| 204 | ACHC | Acadia Healthcare Company, Inc. | 3.23B | 7.88% | 5,539,112 | 3.41B |
| 205 | WRBY | Warby Parker Inc. | 3.23B | 22.50% | 11,263,220 | 934.66M |
| 206 | TLX | Telix Pharmaceuticals Limited | 3.23B | -2.59% | 328,406 | 890.79M |
| 207 | DNLI | Denali Therapeutics Inc. | 3.16B | -5.92% | 2,249,462 | 21.38M |
| 208 | CELC | Celcuity Inc. | 3.13B | -7.51% | 1,423,789 | - |
| 209 | ATRC | AtriCure, Inc. | 3.12B | -6.49% | 979,672 | 589.80M |
| 210 | PRVA | Privia Health Group, Inc. | 3.06B | 6.88% | 3,338,675 | 2.43B |
| 211 | SGRY | Surgery Partners, Inc. | 3.01B | 0.04% | 5,902,513 | 3.37B |
| 212 | AVAH | Aveanna Healthcare Holdings Inc. | 2.98B | -3.94% | 2,322,213 | 2.60B |
| 213 | BHC | Bausch Health Companies Inc. | 2.98B | -4.56% | 3,344,721 | 11.11B |
| 214 | IDYA | IDEAYA Biosciences, Inc. | 2.96B | -5.28% | 1,237,238 | 36.54M |
| 215 | ADMA | ADMA Biologics, Inc. | 2.93B | 26.05% | 15,002,518 | 519.15M |
| 216 | AXGN | Axogen, Inc. | 2.91B | -5.06% | 1,210,102 | 266.93M |
| 217 | ZLAB | Zai Lab Limited | 2.81B | -0.88% | 814,020 | 441.73M |
| 218 | VCEL | Vericel Corporation | 2.65B | 13.85% | 2,682,494 | 324.17M |
| 219 | RGC | Regencell Bioscience Holdings Limited | 2.61B | -2.77% | 179,750 | - |
| 220 | BKD | Brookdale Senior Living Inc. | 2.58B | -3.40% | 9,322,061 | 2.93B |
| 221 | BEAM | Beam Therapeutics Inc. | 2.58B | -6.91% | 2,991,345 | 146.64M |
| 222 | PGNY | Progyny, Inc. | 2.57B | 14.19% | 2,790,552 | 1.34B |
| 223 | XNCR | Xencor, Inc. | 2.56B | -2.80% | 1,433,238 | 200.49M |
| 224 | NEOG | Neogen Corporation | 2.55B | -6.26% | 3,715,882 | 884.00M |
| 225 | RCUS | Arcus Biosciences, Inc. | 2.55B | -8.39% | 2,036,343 | 100.00M |
| 226 | GRDN | Guardian Pharmacy Services, Inc. | 2.53B | -5.27% | 701,200 | 1.46B |
| 227 | HCM | HUTCHMED (China) Limited | 2.46B | 2.01% | 93,107 | 549.12M |
| 228 | MD | Pediatrix Medical Group, Inc. | 2.43B | -2.93% | 905,867 | 1.96B |
| 229 | TMDX | TransMedics Group, Inc. | 2.39B | -5.20% | 1,692,342 | 727.65M |
| 230 | XERS | Xeris Biopharma Holdings, Inc. | 2.39B | 25.05% | 12,599,275 | 368.26M |
| 231 | CLOV | Clover Health Investments, Corp. | 2.39B | -4.48% | 8,258,225 | 2.74B |
| 232 | MBX | MBX Biosciences, Inc. | 2.33B | -7.66% | 427,887 | - |
| 233 | UFPT | UFP Technologies, Inc. | 2.32B | -9.10% | 176,115 | 649.52M |
| 234 | ADUS | Addus HomeCare Corporation | 2.31B | -0.88% | 262,557 | 1.50B |
| 235 | PHVS | Pharvaris N.V. | 2.28B | -5.24% | 932,849 | - |
| 236 | PVLA | Palvella Therapeutics, Inc. | 2.26B | -3.35% | 269,522 | - |
| 237 | NAMS | NewAmsterdam Pharma Company N.V. | 2.26B | -9.75% | 1,560,991 | 25.94M |
| 238 | ARDT | Ardent Health, Inc. | 2.24B | 22.40% | 2,471,501 | 6.45B |
| 239 | CLDX | Celldex Therapeutics, Inc. | 2.22B | -5.55% | 1,111,363 | 158.00K |
| 240 | SEPN | Septerna, Inc. | 2.21B | -1.11% | 533,995 | 98.88M |
| 241 | RXRX | Recursion Pharmaceuticals, Inc. | 2.18B | -9.79% | 25,416,509 | 68.23M |
| 242 | PRGO | Perrigo Company plc | 2.18B | -0.76% | 2,875,544 | 4.09B |
| 243 | AUPH | Aurinia Pharmaceuticals Inc. | 2.17B | -5.26% | 1,139,541 | 321.74M |
| 244 | VERA | Vera Therapeutics, Inc. | 2.17B | -5.72% | 1,421,506 | 10.28M |
| 245 | LKFT | Lakefront Biotherapeutics NV | 2.17B | -1.55% | 342,321 | 1.13B |
| 246 | SDGR | Schrödinger, Inc. | 2.16B | 0.88% | 2,217,584 | 269.20M |
| 247 | NEO | NeoGenomics, Inc. | 2.13B | -3.85% | 2,105,393 | 787.75M |
| 248 | COAG | Hemab Therapeutics Holdings, Inc. | 2.13B | 1.06% | 456,595 | - |
| 249 | IMNM | Immunome, Inc. | 2.11B | -8.27% | 2,206,713 | 4.02M |
| 250 | BHVN | Biohaven Ltd. | 2.10B | -8.79% | 3,472,088 | - |
| 251 | PBH | Prestige Consumer Healthcare Inc. | 2.10B | -16.82% | 1,719,275 | 1.17B |
| 252 | TRLV | Trulieve Cannabis Corp. | 2.10B | -6.03% | 1,496,438 | 1.08B |
| 253 | ZYME | Zymeworks Inc. | 2.04B | -7.13% | 1,224,320 | 37.13M |
| 254 | XRAY | DENTSPLY SIRONA Inc. | 2.01B | -5.26% | 7,865,836 | 3.58B |
| 255 | ASTH | Astrana Health, Inc. | 2.00B | -1.66% | 529,033 | 3.91B |
| 256 | FTRE | Fortrea Holdings Inc. | 1.97B | -1.78% | 2,399,979 | 2.67B |
| 257 | MESO | Mesoblast Limited | 1.96B | -1.33% | 259,261 | 120.25M |
| 258 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.95B | -7.40% | 15,361,600 | 961.51M |
| 259 | VCYT | Veracyte, Inc. | 1.93B | -54.30% | 14,986,383 | 581.78M |
| 260 | INSP | Inspire Medical Systems, Inc. | 1.93B | -0.12% | 1,075,299 | 880.94M |
| 261 | ESTA | Establishment Labs Holdings Inc. | 1.92B | -3.76% | 464,317 | 264.03M |
| 262 | WGS | GeneDx Holdings Corp. | 1.92B | -7.18% | 877,332 | 454.43M |
| 263 | AGL | agilon health, inc. | 1.91B | 18.23% | 585,634 | 6.00B |
| 264 | LMAT | LeMaitre Vascular, Inc. | 1.91B | -5.04% | 533,948 | 269.36M |
| 265 | TRAX | First Tracks Biotherapeutics, Inc. | 1.91B | -7.36% | 571,288 | - |
| 266 | HRMY | Harmony Biosciences Holdings, Inc. | 1.91B | -5.67% | 1,477,534 | 989.36M |
| 267 | REPL | Replimune Group, Inc. | 1.90B | -3.24% | 4,003,447 | - |
| 268 | ALMR | Alamar Biosciences, Inc. | 1.87B | -1.77% | 1,238,753 | 114.05M |
| 269 | VIR | Vir Biotechnology, Inc. | 1.86B | -6.37% | 2,934,534 | 302.80M |
| 270 | CERT | Certara, Inc. | 1.86B | 9.83% | 3,733,153 | 412.03M |
| 271 | SRPT | Sarepta Therapeutics, Inc. | 1.86B | -7.48% | 1,871,621 | 1.96B |
| 272 | AMN | AMN Healthcare Services, Inc. | 1.84B | -0.67% | 904,105 | 3.52B |
| 273 | TRVI | Trevi Therapeutics, Inc. | 1.83B | -8.43% | 1,584,209 | - |
| 274 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.81B | -9.59% | 3,211,989 | 213.00M |
| 275 | MAZE | Maze Therapeutics, Inc. | 1.75B | -2.55% | 643,584 | 20.00M |
| 276 | OMCL | Omnicell, Inc. | 1.75B | -3.50% | 783,368 | 1.24B |
| 277 | TDOC | Teladoc Health, Inc. | 1.72B | -2.99% | 10,421,935 | 2.47B |
| 278 | STOK | Stoke Therapeutics, Inc. | 1.71B | -5.03% | 1,215,520 | 28.21M |
| 279 | KMTS | Kestra Medical Technologies, Ltd. | 1.70B | -6.46% | 730,867 | 106.73M |
| 280 | HCSG | Healthcare Services Group, Inc. | 1.69B | -5.39% | 876,868 | 1.88B |
| 281 | ZBIO | Zenas BioPharma, Inc. | 1.69B | -8.89% | 825,642 | 11.00M |
| 282 | AGIO | Agios Pharmaceuticals, Inc. | 1.69B | -9.91% | 2,551,351 | 140.84M |
| 283 | LYCA | Lycia Therapeutics, Inc. | 1.66B | -0.41% | 189,795 | 4.44M |
| 284 | PSNL | Personalis, Inc. | 1.66B | -1.52% | 3,788,459 | 80.77M |
| 285 | ENOV | Enovis Corporation | 1.65B | 17.20% | 5,591,867 | 2.31B |
| 286 | AZTA | Azenta, Inc. | 1.64B | -4.50% | 1,066,154 | 613.81M |
| 287 | ALVO | Alvotech | 1.62B | -2.57% | 752,749 | 494.61M |
| 288 | BFLY | Butterfly Network, Inc. | 1.62B | -10.34% | 6,674,059 | 123.26M |
| 289 | NRIX | Nurix Therapeutics, Inc. | 1.62B | -6.96% | 7,091,384 | 701.94M |
| 290 | SNDA | Sonida Senior Living, Inc. | 1.61B | -7.97% | 1,199,063 | 593.38M |
| 291 | GENB | Generate Biomedicines, Inc. | 1.61B | -11.23% | 1,303,528 | 26.48M |
| 292 | NVAX | Novavax, Inc. | 1.61B | -8.17% | 8,215,769 | 411.65M |
| 293 | ABSI | Absci Corporation | 1.61B | -10.40% | 5,118,095 | 1.56M |
| 294 | SLS | SELLAS Life Sciences Group, Inc. | 1.59B | -13.79% | 10,739,021 | - |
| 295 | NVCR | NovoCure Limited | 1.58B | -7.26% | 1,994,307 | 725.39M |
| 296 | RARE | Ultragenyx Pharmaceutical Inc. | 1.58B | -9.27% | 5,390,974 | 730.00M |
| 297 | ALHC | Alignment Healthcare, Inc. | 1.58B | -7.13% | 4,958,938 | 4.94B |
| 298 | KLRA | Kailera Therapeutics, Inc. | 1.58B | -4.92% | 842,709 | - |
| 299 | CNMD | CONMED Corporation | 1.57B | -1.55% | 406,922 | 1.37B |
| 300 | NBTX | Nanobiotix S.A. | 1.56B | 1.08% | 567,083 | 13.15M |
| 301 | NTLA | Intellia Therapeutics, Inc. | 1.56B | -9.83% | 7,615,223 | 52.89M |
| 302 | PGEN | Precigen, Inc. | 1.51B | -16.52% | 26,645,215 | 156.94M |
| 303 | ANIP | ANI Pharmaceuticals, Inc. | 1.49B | -2.83% | 1,295,663 | 1.04B |
| 304 | ADRX | ADARx Pharmaceuticals, Inc. | 1.49B | -11.16% | 781,164 | 6.13M |
| 305 | NUVB | Nuvation Bio Inc. | 1.47B | -11.42% | 8,424,396 | 201.73M |
| 306 | IMCR | Immunocore Holdings plc | 1.46B | -2.84% | 372,085 | 430.78M |
| 307 | QURE | uniQure N.V. | 1.46B | -8.77% | 5,135,397 | 20.17M |
| 308 | PCRX | Pacira BioSciences, Inc. | 1.45B | 0.05% | 1,129,713 | 743.30M |
| 309 | USPH | U.S. Physical Therapy, Inc. | 1.45B | 8.99% | 309,306 | 829.86M |
| 310 | PAHC | Phibro Animal Health Corporation | 1.44B | -10.22% | 348,694 | 1.54B |
| 311 | TYRA | Tyra Biosciences, Inc. | 1.44B | -2.97% | 694,656 | - |
| 312 | BRVE | Braveheart Bio, Inc. | 1.42B | -13.40% | 1,590,098 | - |
| 313 | AAPG | Ascentage Pharma Group International | 1.42B | 0.40% | 9,870 | 94.61M |
| 314 | OCUL | Ocular Therapeutix, Inc. | 1.41B | -9.94% | 3,130,016 | 52.06M |
| 315 | RAPP | Rapport Therapeutics, Inc. | 1.41B | -8.52% | 706,972 | 20.00M |
| 316 | PNTG | The Pennant Group, Inc. | 1.41B | -9.17% | 1,700,971 | 1.17B |
| 317 | KRSA | Korsana Biosciences, Inc. | 1.39B | -0.43% | 110,235 | - |
| 318 | CRON | Cronos Group Inc. | 1.38B | 5.98% | 3,971,179 | 206.20M |
| 319 | INVA | Innoviva, Inc. | 1.37B | -9.50% | 2,649,747 | 438.32M |
| 320 | ANAB | AnaptysBio, Inc. | 1.36B | -4.06% | 380,827 | 106.09M |
| 321 | GPCR | Structure Therapeutics Inc. | 1.36B | -6.29% | 1,012,046 | - |
| 322 | DMRA | Damora Therapeutics, Inc. | 1.35B | -4.71% | 792,595 | - |
| 323 | ETON | Eton Pharmaceuticals, Inc. | 1.35B | -7.04% | 706,180 | 141.06M |
| 324 | MLYS | Mineralys Therapeutics, Inc. | 1.35B | -10.35% | 2,548,778 | - |
| 325 | STAA | STAAR Surgical Company | 1.34B | -1.66% | 1,450,851 | 328.27M |
| 326 | TSHA | Taysha Gene Therapies, Inc. | 1.33B | -6.19% | 6,742,979 | 5.49M |
| 327 | NUTX | Nutex Health Inc. | 1.33B | -5.64% | 148,258 | 796.53M |
| 328 | OPK | OPKO Health, Inc. | 1.31B | -1.13% | 9,788,483 | 654.10M |
| 329 | KARD | Kardigan, Inc. | 1.30B | -10.93% | 675,773 | - |
| 330 | LMRI | Lumexa Imaging Holdings, Inc. | 1.27B | 0.84% | 485,571 | 1.04B |
| 331 | GHRS | GH Research PLC | 1.27B | -7.48% | 407,250 | - |
| 332 | URGN | UroGen Pharma Ltd. | 1.26B | -10.47% | 2,472,982 | 250.25M |
| 333 | TNDM | Tandem Diabetes Care, Inc. | 1.25B | -5.56% | 3,026,473 | 1.08B |
| 334 | INNV | InnovAge Holding Corp. | 1.24B | -7.15% | 521,005 | 1.02B |
| 335 | OMER | Omeros Corporation | 1.24B | -6.11% | 994,053 | 38.42M |
| 336 | AORT | Artivion, Inc. | 1.23B | -4.23% | 1,127,744 | 481.88M |
| 337 | NKTR | Nektar Therapeutics | 1.23B | -6.06% | 726,553 | 54.59M |
| 338 | LBRX | LB Pharmaceuticals Inc | 1.23B | -6.76% | 354,371 | - |
| 339 | DRTS | Alpha Tau Medical Ltd. | 1.23B | -5.20% | 671,908 | - |
| 340 | ATEC | Alphatec Holdings, Inc. | 1.21B | -5.80% | 4,087,644 | 839.72M |
| 341 | MNKD | MannKind Corporation | 1.21B | -4.33% | 5,405,349 | 413.37M |
| 342 | GDRX | GoodRx Holdings, Inc. | 1.19B | -6.18% | 1,328,286 | 785.23M |
| 343 | SLN | Silence Therapeutics plc | 1.19B | -0.40% | 1,403,243 | 615.00K |
| 344 | AVLN | Avalyn Pharma Inc. | 1.18B | -2.91% | 476,339 | - |
| 345 | INBX | Inhibrx Biosciences, Inc. | 1.18B | -7.47% | 242,328 | 1.30M |
| 346 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.18B | -1.28% | 607,332 | 745.79M |
| 347 | PRCT | PROCEPT BioRobotics Corporation | 1.17B | -6.42% | 3,108,226 | 352.31M |
| 348 | OMDA | Omada Health, Inc. | 1.16B | -2.47% | 2,072,792 | 333.04M |
| 349 | VOR | Vor Biopharma Inc. | 1.15B | -7.26% | 636,355 | - |
| 350 | SGP | SpyGlass Pharma, Inc. | 1.14B | -1.07% | 191,967 | - |
| 351 | VSTM | Verastem, Inc. | 1.14B | -4.77% | 3,048,442 | 100.30M |
| 352 | FRNM | Freenome, Inc. | 1.12B | -7.35% | 1,328,183 | 35.41M |
| 353 | SVRA | Savara Inc. | 1.11B | -6.01% | 2,900,074 | - |
| 354 | AHG | Akso Health Group | 1.11B | -2.63% | 972 | 13.83M |
| 355 | IART | Integra LifeSciences Holdings Corporation | 1.10B | -4.72% | 992,073 | 1.66B |
| 356 | SIBN | SI-BONE, Inc. | 1.09B | -2.73% | 924,944 | 220.65M |
| 357 | IRMD | IRADIMED CORPORATION | 1.09B | -3.43% | 128,003 | 89.34M |
| 358 | SPTX | Seaport Therapeutics, Inc. | 1.09B | -2.72% | 221,061 | - |
| 359 | CMPS | COMPASS Pathways plc | 1.08B | -9.19% | 5,544,191 | - |
| 360 | CSTL | Castle Biosciences, Inc. | 1.04B | -4.34% | 701,873 | 377.13M |
| 361 | CBLL | CeriBell, Inc. | 1.01B | -5.04% | 955,786 | 108.72M |
| 362 | AHCO | AdaptHealth Corp. | 989.90M | 1.37% | 4,625,656 | 3.44B |
| 363 | JANX | Janux Therapeutics, Inc. | 981.86M | -11.66% | 893,135 | 23.29M |
| 364 | HROW | Harrow, Inc. | 976.18M | -9.43% | 701,969 | 275.59M |
| 365 | GMRS | GMR Solutions Inc. | 972.30M | 0.97% | 969,181 | 5.88B |
| 366 | MLTX | MoonLake Immunotherapeutics | 919.15M | -6.57% | 1,337,583 | - |
| 367 | HSTM | HealthStream, Inc. | 905.64M | -8.87% | 387,232 | 327.95M |
| 368 | ODTX | Odyssey Therapeutics, Inc. | 904.70M | -3.18% | 433,830 | 99.00K |
| 369 | BVS | Bioventus Inc. | 899.91M | -6.48% | 806,759 | 585.64M |
| 370 | JBIO | Jade Biosciences, Inc. | 896.72M | -6.25% | 1,286,833 | - |
| 371 | IVA | Inventiva S.A. | 890.92M | -6.20% | 2,535,445 | 2.81M |
| 372 | QDEL | QuidelOrtho Corporation | 880.99M | -10.52% | 4,126,809 | 2.59B |
| 373 | PHAR | Pharming Group N.V. | 880.06M | -1.28% | 12,583 | 386.75M |
| 374 | ORIC | ORIC Pharmaceuticals, Inc. | 880.01M | -9.10% | 1,390,438 | - |
| 375 | GLUE | Monte Rosa Therapeutics, Inc. | 874.46M | -5.27% | 1,714,981 | 70.33M |
| 376 | LTGO | Latigo Biotherapeutics, Inc. | 862.55M | -7.34% | 424,278 | - |
| 377 | ANRO | Alto Neuroscience, Inc. | 858.22M | -6.14% | 411,279 | - |
| 378 | RIGL | Rigel Pharmaceuticals, Inc. | 853.86M | -10.88% | 551,003 | 288.21M |
| 379 | CTY | City Therapeutics, Inc. | 849.35M | 4.02% | 214,042 | 14.34M |
| 380 | IMTX | Immatics N.V. | 844.74M | -10.56% | 1,278,172 | 47.65M |
| 381 | SNDX | Syndax Pharmaceuticals, Inc. | 843.56M | -10.33% | 5,794,060 | 289.68M |
| 382 | BBNX | Beta Bionics, Inc. | 842.15M | -8.61% | 2,077,525 | 127.27M |
| 383 | KIDS | OrthoPediatrics Corp. | 841.28M | -3.85% | 326,694 | 264.14M |
| 384 | AKTS | Aktis Oncology, Inc. | 825.95M | -2.30% | 440,447 | 10.06M |
| 385 | COLL | Collegium Pharmaceutical, Inc. | 819.10M | 6.29% | 1,573,887 | 815.19M |
| 386 | CRVS | Corvus Pharmaceuticals, Inc. | 818.50M | -7.95% | 1,145,705 | - |
| 387 | MGTX | MeiraGTx Holdings plc | 817.33M | -9.66% | 686,678 | 397.50M |
| 388 | BBTX | Bambusa Therapeutics, Inc. | 807.44M | -1.37% | 420,634 | - |
| 389 | PRME | Prime Medicine, Inc. | 791.67M | -10.46% | 4,747,791 | 4.07M |
| 390 | PHR | Phreesia, Inc. | 788.92M | -3.57% | 729,356 | 507.79M |
| 391 | VREX | Varex Imaging Corporation | 777.21M | -0.38% | 637,886 | 865.00M |
| 392 | INMD | InMode Ltd. | 770.24M | -5.63% | 652,081 | 374.63M |
| 393 | ANNX | Annexon, Inc. | 759.26M | -7.51% | 4,359,974 | - |
| 394 | ALMS | Alumis Inc. | 757.20M | -10.69% | 1,950,464 | 7.40M |
| 395 | PACB | Pacific Biosciences of California, Inc. | 755.32M | -4.71% | 20,583,854 | 161.39M |
| 396 | ARDX | Ardelyx, Inc. | 751.60M | -9.12% | 7,766,728 | 468.22M |
| 397 | ABUS | Arbutus Biopharma Corporation | 726.10M | -9.61% | 6,159,887 | 181.72M |
| 398 | LXRX | Lexicon Pharmaceuticals, Inc. | 716.38M | 8.78% | 3,796,224 | 38.54M |
| 399 | CTKB | Cytek Biosciences, Inc. | 706.17M | -8.16% | 1,472,562 | 207.65M |
| 400 | OABI | OmniAb, Inc. | 704.51M | -6.76% | 1,246,561 | 40.21M |
| 401 | SANA | Sana Biotechnology, Inc. | 700.50M | -8.59% | 3,086,307 | - |
| 402 | CGEM | Cullinan Therapeutics, Inc. | 695.03M | -13.53% | 1,789,229 | - |
| 403 | ATTO | Attovia Therapeutics, Inc. | 684.77M | -3.85% | 376,125 | 1.80M |
| 404 | STLN | Starling Oncology, Inc. | 682.84M | -3.46% | 2,081,124 | 620.45M |
| 405 | DNA | Ginkgo Bioworks Holdings, Inc. | 670.71M | -14.51% | 2,374,765 | 130.75M |
| 406 | IRWD | Ironwood Pharmaceuticals, Inc. | 665.92M | 6.90% | 4,989,224 | 400.30M |
| 407 | SLDB | Solid Biosciences Inc. | 662.65M | -5.21% | 1,436,086 | - |
| 408 | AURA | Aura Biosciences, Inc. | 657.49M | -4.66% | 790,866 | - |
| 409 | ACHV | Achieve Life Sciences, Inc. | 656.00M | -8.67% | 1,812,335 | - |
| 410 | SGMT | Sagimet Biosciences Inc. | 646.69M | -8.71% | 1,154,561 | - |
| 411 | WVE | Wave Life Sciences, Inc. | 635.08M | -11.05% | 5,323,153 | 70.92M |
| 412 | ZVRA | Zevra Therapeutics, Inc. | 626.58M | -5.73% | 1,676,174 | 147.76M |
| 413 | ANL | Adlai Nortye Group Ltd. | 623.37M | 0.73% | 450,321 | 18.06M |
| 414 | NVCT | Nuvectis Pharma, Inc. | 622.17M | -3.84% | 340,098 | - |
| 415 | FDMT | 4D Molecular Therapeutics, Inc. | 621.50M | -8.39% | 1,598,598 | 92.01M |
| 416 | EVO | Evotec SE | 616.77M | 13.06% | 273,775 | 815.72M |
| 417 | CADL | Candel Therapeutics, Inc. | 615.21M | -11.16% | 1,228,486 | - |
| 418 | HELP | Helus Pharma Inc. | 612.97M | -3.34% | 1,445,951 | - |
| 419 | GERN | Geron Corporation | 612.09M | -12.03% | 25,833,003 | 217.52M |
| 420 | DBVT | DBV Technologies S.A. | 611.06M | -1.41% | 414,635 | 3.74M |
| 421 | DSGN | Design Therapeutics, Inc. | 605.16M | -9.03% | 748,914 | - |
| 422 | KURA | Kura Oncology, Inc. | 604.93M | -10.64% | 3,601,830 | 77.23M |
| 423 | AVBP | ArriVent BioPharma, Inc. | 603.03M | -9.34% | 1,101,870 | - |
| 424 | MYGN | Myriad Genetics, Inc. | 601.95M | 4.49% | 3,599,454 | 803.60M |
| 425 | IMMX | Immix Biopharma, Inc. | 596.90M | -9.66% | 1,414,763 | - |
| 426 | OBX | Obsidian Therapeutics, Inc. | 593.02M | -12.65% | 778,315 | - |
| 427 | OLMA | Olema Pharmaceuticals, Inc. | 591.48M | -10.34% | 1,704,167 | - |
| 428 | TCMD | Tactile Systems Technology, Inc. | 590.72M | -2.98% | 251,617 | 356.42M |
| 429 | APMD | Apnimed, Inc. | 589.49M | -7.45% | 448,294 | 115.12M |
| 430 | SOPH | SOPHiA GENETICS SA | 567.06M | -5.02% | 757,344 | 90.97M |
| 431 | ACRS | Aclaris Therapeutics, Inc. | 559.49M | -1.90% | 2,330,024 | 6.40M |
| 432 | CBIO | Crescent Biopharma, Inc. | 553.85M | -6.37% | 191,583 | 11.88M |
| 433 | IAM | Iambic Therapeutics, Inc. | 551.75M | -13.13% | 751,873 | 18.25M |
| 434 | AVR | Anteris Technologies Global Corp. | 544.01M | -8.82% | 1,891,678 | 2.24M |
| 435 | VALN | Valneva SE | 543.98M | 0.18% | 5,385 | 163.30M |
| 436 | BCAX | Bicara Therapeutics Inc. | 541.96M | -7.87% | 1,109,233 | - |
| 437 | NRC | NRC Health | 540.72M | -5.87% | 255,626 | 143.79M |
| 438 | SGHT | Sight Sciences, Inc. | 537.66M | 0.83% | 1,073,665 | 88.40M |
| 439 | ENTX | Entera Bio Ltd. | 520.03M | -3.86% | 219,763 | 42.00K |
| 440 | FTH | Faeth Therapeutics, Inc. | 514.74M | -0.35% | 270,613 | - |
| 441 | FLGT | Fulgent Genetics, Inc. | 513.44M | -5.18% | 388,387 | 330.28M |
| 442 | SLBT | SL Science Holding Limited | 513.30M | -18.91% | 142,226 | 3.27M |
| 443 | NGNE | Neurogene Inc. | 513.29M | -7.00% | 380,859 | 925.00K |
| 444 | EVH | Evolent Health, Inc. | 513.29M | -5.42% | 3,500,129 | 2.34B |
| 445 | CLYM | Climb Bio, Inc. | 509.46M | -4.93% | 1,435,455 | - |
| 446 | YDES | YD Bio Limited | 508.57M | 3.31% | 76,917 | 1.24M |
| 447 | SRZN | Surrozen, Inc. | 507.36M | -8.37% | 219,975 | 11.51M |
| 448 | PBYI | Puma Biotechnology, Inc. | 504.33M | -8.61% | 490,930 | 231.87M |
| 449 | MCTA | Charming Medical Limited | 504.26M | -0.02% | 4,251,392 | 4.81M |
| 450 | OVID | Ovid Therapeutics Inc. | 503.87M | -5.84% | 2,016,184 | 1.58M |
| 451 | DCTH | Delcath Systems, Inc. | 502.79M | -2.23% | 554,122 | 95.42M |
| 452 | CAPR | Capricor Therapeutics, Inc. | 500.00M | -3.59% | 4,717,867 | 11.13M |
| 453 | ANGO | AngioDynamics, Inc. | 496.66M | -3.59% | 488,145 | 325.38M |
| 454 | DMAC | DiaMedica Therapeutics Inc. | 487.49M | -16.06% | 330,471 | - |
| 455 | RGNX | REGENXBIO Inc. | 487.18M | -4.28% | 1,677,427 | 153.91M |
| 456 | TKNO | Alpha Teknova, Inc. | 486.22M | 6.92% | 1,065,905 | 45.95M |
| 457 | INDP | Indaptus Therapeutics, Inc. | 485.32M | -4.24% | 204,561 | - |
| 458 | RCEL | AVITA Medical, Inc. | 484.93M | -3.92% | 713,769 | 75.63M |
| 459 | MDXG | MiMedx Group, Inc. | 478.64M | 2.50% | 2,832,732 | 303.73M |
| 460 | SRTA | Strata Critical Medical, Inc. | 469.82M | 0.77% | 1,731,819 | 280.76M |
| 461 | JSPR | Jasper Therapeutics, Inc. | 468.37M | -8.18% | 17,862 | - |
| 462 | CTMX | CytomX Therapeutics, Inc. | 466.30M | -8.94% | 3,862,096 | 14.03M |
| 463 | ETRA | Electra Therapeutics, Inc. | 461.34M | -7.78% | 529,340 | - |
| 464 | AQST | Aquestive Therapeutics, Inc. | 460.02M | -3.68% | 3,257,238 | 48.84M |
| 465 | MNPR | Monopar Therapeutics Inc. | 451.19M | -7.68% | 157,521 | - |
| 466 | STTK | Shattuck Labs, Inc. | 450.63M | -12.82% | 1,434,776 | 1.00M |
| 467 | EOLS | Evolus, Inc. | 449.44M | -9.04% | 2,129,489 | 325.47M |
| 468 | BWAY | BrainsWay Ltd. | 441.01M | -5.35% | 91,760 | 60.70M |
| 469 | NPCE | NeuroPace, Inc. | 435.58M | -4.87% | 122,031 | 106.99M |
| 470 | EPRX | Eupraxia Pharmaceuticals Inc. | 434.76M | -2.37% | 789,540 | - |
| 471 | CERS | Cerus Corporation | 430.16M | -11.80% | 2,453,711 | 226.57M |
| 472 | ARVN | Arvinas, Inc. | 428.93M | -11.73% | 1,261,351 | 275.30M |
| 473 | GYRE | Gyre Therapeutics, Inc. | 425.20M | -9.68% | 266,664 | 110.06M |
| 474 | SI | Shoulder Innovations, Inc. | 424.08M | -3.05% | 121,325 | 64.49M |
| 475 | SENS | Senseonics Holdings, Inc. | 422.46M | -11.42% | 796,867 | 48.55M |
| 476 | OCS | Oculis Holding AG | 421.63M | -6.18% | 371,649 | 1.12M |
| 477 | MASS | 908 Devices Inc. | 419.54M | -8.31% | 475,753 | 60.84M |
| 478 | CARL | Carlsmed, Inc. | 418.28M | -4.79% | 99,581 | 63.30M |
| 479 | TLRY | Tilray Brands, Inc. | 412.12M | -5.07% | 6,742,468 | 963.10M |
| 480 | CRMD | CorMedix Inc. | 407.65M | -7.60% | 1,834,485 | 462.25M |
| 481 | ASMB | Assembly Biosciences, Inc. | 407.21M | 0.65% | 518,400 | 74.85M |
| 482 | PRTA | Prothena Corporation plc | 405.05M | -5.96% | 518,499 | 52.74M |
| 483 | PHAT | Phathom Pharmaceuticals, Inc. | 403.50M | -10.56% | 1,552,395 | 274.88M |
| 484 | RLMD | Relmada Therapeutics, Inc. | 402.15M | -9.59% | 1,486,559 | - |
| 485 | BLSM | BlossomHill Therapeutics, Inc. | 392.54M | -0.24% | 351,542 | - |
| 486 | EDIT | Editas Medicine, Inc. | 391.63M | -6.25% | 2,098,709 | 47.01M |
| 487 | KMDA | Kamada Ltd. | 389.55M | -7.41% | 257,229 | 191.85M |
| 488 | ALT | Altimmune, Inc. | 383.20M | -7.08% | 4,205,667 | 31.00K |
| 489 | RZLT | Rezolute, Inc. | 381.82M | -8.08% | 1,228,076 | - |
| 490 | SSII | SS Innovations International, Inc. | 380.73M | -16.30% | 140,560 | 52.40M |
| 491 | TECX | Tectonic Therapeutic, Inc. | 379.65M | -4.33% | 109,568 | - |
| 492 | ALLO | Allogene Therapeutics, Inc. | 376.59M | -8.40% | 15,292,646 | 4.64M |
| 493 | MOBI | Mobia Medical, Inc. | 375.52M | 0.36% | 183,646 | 51.89M |
| 494 | LYEL | Lyell Immunopharma, Inc. | 368.78M | -2.79% | 658,413 | 15.00K |
| 495 | PRLD | Prelude Therapeutics Incorporated | 366.15M | -12.87% | 207,871 | 22.42M |
| 496 | OFIX | Orthofix Medical Inc. | 363.33M | -8.23% | 1,362,333 | 833.19M |
| 497 | CCCC | C4 Therapeutics, Inc. | 362.92M | -5.45% | 3,684,324 | 32.28M |
| 498 | EMBC | Embecta Corp. | 358.66M | -2.91% | 780,109 | 1.02B |
| 499 | ZURA | Zura Bio Limited | 358.33M | -7.46% | 2,656,655 | - |
| 500 | AVTX | Avalo Therapeutics, Inc. | 355.57M | -6.22% | 1,258,173 | 59.00K |